PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) saw a large increase in short interest in September. As of September 15th, there was short interest totaling 35,490 shares, an increase of 98.5% from the August 31st total of 17,878 shares. Based on an average trading volume of 317,265 shares, the days-to-cover ratio is currently 0.1 days.
PharmaTher Price Performance
Shares of PHRRF remained flat at $0.04 during trading hours on Wednesday. The stock had a trading volume of 7,535 shares, compared to its average volume of 160,487. The firm has a fifty day moving average of $0.04 and a 200 day moving average of $0.05. PharmaTher has a one year low of $0.03 and a one year high of $0.29.
PharmaTher Company Profile
PharmaTher Inc is a specialty pharmaceutical company focused on developing and commercializing therapies for diseases with significant unmet medical needs. The company’s strategy centers on repurposing established medicines and advancing pharmaceutical products through clinical development and regulatory pathways.
PharmaTher has primarily focused on ketamine-based treatments and psychedelic medicines. Its development programs have included potential applications of ketamine in neurological and psychiatric conditions, including status epilepticus, Parkinson’s disease and related movement disorders.
See Also
- Five stocks we like better than PharmaTher
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
- 3 Emerging Biotech Stocks With Significant Upside Potential
- Treasury Yields Haven’t Been This High Since 2007—3 ETFs to Watch
- 3 Healthcare Dividend Stocks Offering More Than Just Income
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
